Modulation of Serotonin Receptors in Neurodevelopmental Disorders: Focus on 5-HT7 Receptor
Since neurodevelopmental disorders (NDDs) influence more than 3% of children worldwide, there has been intense investigation to understand the etiology of disorders and develop treatments. Although there are drugs such as aripiprazole, risperidone, and lurasidone, these medications are not cures for...
Main Authors: | Jieon Lee, Diana Avramets, Byungsun Jeon, Hyunah Choo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/11/3348 |
Similar Items
-
5-HT7 receptors as modulators of neuronal excitability, synaptic transmission and plasticity: physiological role and possible implications in autism spectrum disorders
by: Lucia eCiranna, et al.
Published: (2014-08-01) -
Insulin-Like Growth Factor 1 and Related Compounds in the Treatment of Childhood-Onset Neurodevelopmental Disorders
by: Cyrus Vahdatpour, et al.
Published: (2016-09-01) -
Epigenetic Regulations in Neuropsychiatric Disorders
by: Janise N. Kuehner, et al.
Published: (2019-04-01) -
<i>FMR1</i> and Autism, an Intriguing Connection Revisited
by: William Fyke, et al.
Published: (2021-08-01) -
Metabotropic Glutamate Receptor 7: A New Therapeutic Target in Neurodevelopmental Disorders
by: Nicole M. Fisher, et al.
Published: (2018-10-01)